MacroGenics Announces Date of Fourth Quarter 2022 Financial
ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and......
Broadwind Reports Fourth Quarter and Full-Year 2022
CICERO, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions......
Arbutus to Report Fourth Quarter and Year End 2022
WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging......
Retail Opportunity Investments Corp. Reports 2022 Results
SAN DIEGO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the......